The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants
Mingyue Guo(Huazhong Agricultural University), Yuguo Chen(Qilu Hospital of Shandong University), Qi Han(Army Medical University), Chuanbao Li(Academy of Medical Sciences), Jiaxuan Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Chang Pan(Shandong University), Qiuhuan Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Shengchuan Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xingfang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xue Li(Jiangsu University), Jiali Wang(Kunming Medical University), Feng Xu(Qilu Hospital of Shandong University), Yuan Bian(Ministry of Education of the People's Republic of China), Hao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaojiao Pang(Qilu Hospital of Shandong University), Panpan Hao(Ningxia Medical University), Yanshan De(Chinese Academy of Medical Sciences & Peking Union Medical College), Zechen Shan(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
Traditional Chinese Medicine for Cardiovascular Disease
|Journal of the American College of Cardiology|2017|592
Overfeeding Rapidly Induces Leptin and Insulin Resistance
|Diabetes|2001|356
Angiotensin IV attenuates diabetic cardiomyopathy <i>via</i> suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis
|Theranostics|2021|150
Traditional Chinese medication for cardiovascular disease
|Nature Reviews Cardiology|2014|134